Author:
Feng Yan,Lu Shu-li,Jin Xiang-gong,Gao Jie,Chen Wan-pin,Wang Yi-xin,Xu Hao,Wang Lu-ya
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference21 articles.
1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.
2. Feng Y, Xu H, Chen K. Natural polypill Xuezhikang: its clinical benefit and potential multicomponent synergistic mechanisms of action in cardiovascular disease and other chronic conditions. J Altern Complement Med 2012;4:318–328.
3. Mignarri A, Magni A, Del Puppo M, Gallus GN, Björkhem I, Federico A, et al. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis. J Inherit Metab Dis 2016;39:75–83.
4. Chen PP, Jiang L, Wang W, Wen WH, Kuang ZM, Wang LY. Effect of Xuezhikang on serum cholesterol metabolism markers in patients with hypercholesterolemia. Chin Med (Chin) 2017;1:28–32.
5. Xu HY, Xiang ZM, Lu ZL. Summary and interpretation of guidelines for prevention and treatment of dyslipidemia in Chinese adults (2007). Chin J Geriatr Heart Brain Vessel Dis (Chin) 2008;3:238–239.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献